Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

The burden of hepatitis C in the United States.

Kim WR.

Hepatology. 2002 Nov;36(5 Suppl 1):S30-4. Review.

PMID:
12407574
2.

Epidemiology of hepatitis C in the United States.

Williams I.

Am J Med. 1999 Dec 27;107(6B):2S-9S.

PMID:
10653448
3.

Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.

Seeff LB, Hoofnagle JH.

Clin Liver Dis. 2003 Feb;7(1):261-87. Review.

PMID:
12691470
4.

The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States.

Armstrong GL, Alter MJ, McQuillan GM, Margolis HS.

Hepatology. 2000 Mar;31(3):777-82.

PMID:
10706572
5.

Epidemiology of hepatitis C.

Alter MJ.

Hepatology. 1997 Sep;26(3 Suppl 1):62S-65S. Review.

PMID:
9305666
6.

Projecting future complications of chronic hepatitis C in the United States.

Davis GL, Albright JE, Cook SF, Rosenberg DM.

Liver Transpl. 2003 Apr;9(4):331-8.

7.

Epidemiologic trends in infection, mortality, and transplants related to hepatitis C in Wisconsin.

Gasiorowicz M, Hurie M, Russell A, Hoxie N, Vergeront J.

WMJ. 2006 Jan;105(1):34-9.

8.

Opportunities to address the hepatitis C epidemic in the correctional setting.

Boutwell AE, Allen SA, Rich JD.

Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S367-72.

9.

HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality.

Mühlberger N, Schwarzer R, Lettmeier B, Sroczynski G, Zeuzem S, Siebert U.

BMC Public Health. 2009 Jan 22;9:34. doi: 10.1186/1471-2458-9-34. Review.

10.

The cost-effectiveness of testing for hepatitis C in former injecting drug users.

Castelnuovo E, Thompson-Coon J, Pitt M, Cramp M, Siebert U, Price A, Stein K.

Health Technol Assess. 2006 Sep;10(32):iii-iv, ix-xii, 1-93.

11.

Hepatitis C: Part I. Routine serologic testing and diagnosis.

Moyer LA, Mast EE, Alter MJ.

Am Fam Physician. 1999 Jan 1;59(1):79-88, 91-2. Review.

12.

Outcome of hospital care of liver disease associated with hepatitis C in the United States.

Kim WR, Gross JB Jr, Poterucha JJ, Locke GR 3rd, Dickson ER.

Hepatology. 2001 Jan;33(1):201-6.

PMID:
11124837
13.

Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality.

Lehman EM, Wilson ML.

J Viral Hepat. 2009 Sep;16(9):650-8. doi: 10.1111/j.1365-2893.2009.01115.x. Epub 2009 Apr 20.

PMID:
19413698
14.

The epidemiology of hepatitis C infection in the United States.

Rustgi VK.

J Gastroenterol. 2007 Jul;42(7):513-21. Epub 2007 Jul 25. Review.

PMID:
17653645
15.

Outcome of screening for hepatitis C virus infection based on risk factors.

Mallette C, Flynn MA, Promrat K.

Am J Gastroenterol. 2008 Jan;103(1):131-7. Epub 2007 Sep 25.

PMID:
17894850
16.

The costs of not treating hepatitis C virus infection in injecting drug users in New Zealand.

Sheerin IG, Green FT, Sellman JD.

Drug Alcohol Rev. 2003 Jun;22(2):159-67.

PMID:
12850902
17.

Hepatocellular carcinoma and hepatitis C in the United States.

El-Serag HB.

Hepatology. 2002 Nov;36(5 Suppl 1):S74-83. Review.

PMID:
12407579
18.
19.

The epidemiology of hepatitis C virus infection. An update for clinicians.

Pellicano R, Mladenova I, Dimitrova SM, Bruno CM, Sciacca C, Rizzetto M.

Minerva Gastroenterol Dietol. 2004 Mar;50(1):1-7. Review.

PMID:
15719001
20.

Trends in health care resource use for hepatitis C virus infection in the United States.

Grant WC, Jhaveri RR, McHutchison JG, Schulman KA, Kauf TL.

Hepatology. 2005 Dec;42(6):1406-13.

PMID:
16317670
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk